Clinical Trials in Jungnam, South Korea
4 recruiting
Showing 1–2 of 2 trials
Recruiting
Phase 4
A Study of Filgotinib 200 mg in Korean Participants With Moderately to Severely Active Ulcerative Colitis Under Routine Clinical Practice
Ulcerative Colitis
Eisai Korea Inc.94 enrolled19 locationsNCT06964113
Recruiting
Phase 4
Tailored Versus Coventional AntiPlaTelet Strategy Intended After OPTIMIZEd Drug Eluting Stent
Coronary Artery Disease
Asan Medical Center3,944 enrolled25 locationsNCT05418556